Somatuline Autogel

Land: Nýja-Sjáland

Tungumál: enska

Heimild: Medsafe (Medicines Safety Authority)

Virkt innihaldsefni:

Lanreotide 24.6%{relative} (as 50.7 %w/w lanreotide acetate)

Fáanlegur frá:

New Zealand Medical & Scientific Ltd

INN (Alþjóðlegt nafn):

Lanreotide 24.6% w/w (as 50.7 %w/w lanreotide acetate)

Skammtar:

24.6 mg/mL

Lyfjaform:

Solution for injection

Samsetning:

Active: Lanreotide 24.6%{relative} (as 50.7 %w/w lanreotide acetate) Excipient: Glacial acetic acid Water for injection

Einingar í pakka:

Syringe, single dose 60mg (not marketed), 60 mg

Tegund:

Prescription

Gerð lyfseðils:

Prescription

Framleitt af:

Ipsen Manufacturing Ireland Limited

Ábendingar:

Latest Regulatory Activity

Vörulýsing:

Package - Contents - Shelf Life: Syringe, plastic, (PP) with safety shield containing 266 mg of lanreotide 24.6% w/w solution in sealed sachet - 60 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) protect from light - Syringe, plastic, (PP) with safety shield containing 388 mg of lanreotide 24.6% w/w solution in sealed sachet - 90 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) protect from light - Syringe, plastic, (PP) with safety shield containing 510 mg of lanreotide 24.6% w/w solution in sealed sachet - 120 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) protect from light

Leyfisdagur:

2002-05-10